At GoBroad Healthcare Group, stem cell transplantation is more than a procedure—it’s a lifeline for patients facing complex hematologic conditions. With decades of expertise and a network of hospitals across Beijing, Shanghai, and Guangzhou, we’ve refined transplantation protocols to address even the most challenging cases. Our focus on innovation, precision, and patient-centered care has established us as a global destination for those seeking advanced stem cell transplantation solutions.

Mastering Complexity in Stem Cell Transplantation

Our transplantation team thrives on cases others might deem insurmountable. Whether it’s a 72-year-old adult or an infant as young as one month, we’ve successfully performed thousands of stem cell transplants, achieving outcomes that align with international benchmarks. What sets us apart is our adaptability in selecting transplant methods—sibling-matched, haploidentical, cord blood, or salvage transplants—tailored to each patient’s unique needs. For instance, patients with refractory leukemia or relapsed lymphomas often require nuanced approaches, such as bridging stem cell transplantation with CAR-T therapy to eradicate residual disease. This integration of modalities has proven critical for cases like those with high-risk genetic mutations, where precision in timing and technique determines success. Our ability to individualize pre-transplant conditioning and post-transplant immunotherapy ensures minimal complications and maximizes long-term remission rates.

A Collaborative Framework for Transplant Success

Behind every stem cell transplantation at GoBroad lies a multidisciplinary team of hematologists, infection specialists, geneticists, and supportive care experts. Consider patients like Yiyi, who faced recurrent relapses of T-cell lymphoblastic lymphoma. While her prior treatments focused solely on chemotherapy, our team identified an underlying cytomegalovirus infection complicating her case. By resolving the infection through antiviral therapy before considering transplantation, we created a stable foundation for curative treatment. Similarly, Nawal, a Middle Eastern patient with spinal metastases, required coordinated spine surgery and radiation before her transplant could proceed safely. This collaborative model extends to our labs, where genetic profiling and pharmacogenetic testing guide decisions on donor compatibility and post-transplant drug regimens. By uniting diverse specialties, we mitigate risks like graft-versus-host disease or opportunistic infections, ensuring smoother recoveries.

Global Reach, Personalized Journeys

Stem cell transplantation at GoBroad transcends borders. International patients, such as Kirill from Russia with advanced lung cancer, often arrive after exhausting local options. While his primary treatment involved targeted therapy, our readiness to combine emerging drugs with supportive transplants exemplifies our holistic approach. For families traveling from Kazakhstan or the Middle East, we eliminate logistical hurdles through multilingual coordination, expedited donor searches, and culturally sensitive care. Take Lele, an 8-year-old Hodgkin lymphoma patient: after chemotherapy-induced remission, our team monitored his eligibility for future transplants should relapse occur, providing his family with a clear, adaptive roadmap. This global accessibility is bolstered by partnerships with international experts, ensuring our protocols reflect the latest advancements in stem cell transplantation and hematologic research.

Conclusion

GoBroad Healthcare Group redefines what’s possible in stem cell transplantation through relentless innovation and compassionate precision. From high-risk pediatric cases to elderly patients with complex comorbidities, our tailored strategies and collaborative ethos unlock pathways to recovery.